Information Provided By:
Fly News Breaks for January 10, 2020
Jan 10, 2020 | 06:01 EDT
Oppenheimer analyst Jay Olson downgraded Portola Pharmaceuticals to Perform from Outperform with a price target of $17, down from $40.
News For PTLA From the Last 2 Days
There are no results for your query PTLA